Payment overview · 2025
General Payments
$19.77
1 reported records · 1 companies
Healthcare provider profile · identity verified
Mohammad A Joud, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · BROOKSVILLE, FL · NPI 1578513313
Verified facts
What the public records show
CMS Open Payments records show Mohammad A Joud, M.D. received $19.77 in general payments during 2025 across 1 reported records.
AstraZeneca Pharmaceuticals LP accounted for 100.0% of that reported general-payment amount.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $19.77 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $19.77 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
Payment records were found, but the reported records did not identify a specific associated product for this analysis.
Public prescribing for products named in payments
There is no explicit payment-product set available for a Part D comparison.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 631 | 154 |
| Amlodipine Besylate | Amlodipine Besylate | 472 | 120 |
| Atorvastatin Calcium | Atorvastatin Calcium | 455 | 121 |
| Losartan Potassium | Losartan Potassium | 453 | 119 |
| Gabapentin | Gabapentin | 358 | 81 |
| Alprazolam | Alprazolam | 299 | 76 |
| Metoprolol Succinate | Metoprolol Succinate | 291 | 78 |
| Omeprazole | Omeprazole | 277 | 80 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 274 | 77 |
| Metoprolol Tartrate | Metoprolol Tartrate | 269 | 69 |
| Pantoprazole Sodium | Pantoprazole Sodium | 258 | 72 |
| Metformin Hcl | Metformin Hcl | 236 | 61 |
| Eliquis | Apixaban | 231 | 52 |
| Furosemide | Furosemide | 225 | 59 |
| Atenolol | Atenolol | 224 | 59 |
| Clopidogrel | Clopidogrel Bisulfate | 202 | 49 |
| Prednisone | Prednisone | 193 | 62 |
| Potassium Chloride | Potassium Chloride | 187 | 54 |
| Spironolactone | Spironolactone | 179 | 43 |
| Glimepiride | Glimepiride | 168 | 45 |
| Trazodone Hcl | Trazodone Hcl | 166 | 46 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 154 | 56 |
| Tamsulosin Hcl | Tamsulosin Hcl | 154 | 43 |
| Hydrochlorothiazide | Hydrochlorothiazide | 153 | 44 |
| Pravastatin Sodium | Pravastatin Sodium | 146 | 40 |
| Lovastatin | Lovastatin | 145 | 36 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 144 | 27 |
| Simvastatin | Simvastatin | 135 | 37 |
| Temazepam | Temazepam | 123 | 25 |
| Famotidine | Famotidine | 119 | 35 |
| Tizanidine Hcl | Tizanidine Hcl | 117 | 32 |
| Methylprednisolone | Methylprednisolone | 116 | 90 |
| Cefdinir | Cefdinir | 112 | 87 |
| Finasteride | Finasteride | 111 | 26 |
| Meloxicam | Meloxicam | 109 | 33 |
| Lisinopril | Lisinopril | 107 | 30 |
| Tramadol Hcl | Tramadol Hcl | 103 | 27 |
| Doxazosin Mesylate | Doxazosin Mesylate | 102 | 26 |
| Montelukast Sodium | Montelukast Sodium | 101 | 29 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 100 | 27 |
| Azithromycin | Azithromycin | 99 | 81 |
| Zolpidem Tartrate | Zolpidem Tartrate | 95 | 22 |
| Escitalopram Oxalate | Escitalopram Oxalate | 88 | 21 |
| Hydralazine Hcl | Hydralazine Hcl | 85 | 20 |
| Sertraline Hcl | Sertraline Hcl | 82 | 22 |
| Synthroid | Levothyroxine Sodium | 76 | 20 |
| Allopurinol | Allopurinol | 72 | 19 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 72 | 57 |
| Fluoxetine Hcl | Fluoxetine Hcl | 69 | 14 |
| Lamotrigine | Lamotrigine | 67 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 66 | 20 |
| Citalopram Hbr | Citalopram Hydrobromide | 65 | 19 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 65 | 23 |
| Meclizine Hcl | Meclizine Hcl | 65 | 21 |
| Cephalexin | Cephalexin | 63 | 34 |
| Clonazepam | Clonazepam | 63 | 16 |
| Ezetimibe | Ezetimibe | 63 | 19 |
| Amiodarone Hcl | Amiodarone Hcl | 62 | suppressed |
| Bumetanide | Bumetanide | 59 | 20 |
| Doxycycline Hyclate | Doxycycline Hyclate | 59 | 34 |
| Ropinirole Hcl | Ropinirole Hcl | 58 | 12 |
| Irbesartan | Irbesartan | 57 | 13 |
| Telmisartan | Telmisartan | 57 | 19 |
| Diazepam | Diazepam | 56 | 14 |
| Fluticasone Propionate | Fluticasone Propionate | 55 | 26 |
| Oxycodone Hcl | Oxycodone Hcl | 55 | 18 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 55 | 29 |
| Carvedilol | Carvedilol | 54 | 16 |
| Paroxetine Hcl | Paroxetine Hcl | 52 | 13 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 51 | 16 |
| Mounjaro | Tirzepatide | 51 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 50 | 13 |
| Ibuprofen | Ibuprofen | 49 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 48 | 17 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 48 | 13 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 45 | 15 |
| Warfarin Sodium | Warfarin Sodium | 45 | 11 |
| Cefuroxime | Cefuroxime Axetil | 44 | 41 |
| Januvia | Sitagliptin Phosphate | 43 | 12 |
| Jardiance | Empagliflozin | 43 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 43 | 13 |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 42 | suppressed |
| Ozempic | Semaglutide | 42 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 42 | 14 |
| Fenofibrate | Fenofibrate | 41 | 12 |
| Humulin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 41 | suppressed |
| Amoxicillin | Amoxicillin | 40 | 26 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 40 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 39 | 11 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 35 | suppressed |
| Paxlovid | Nirmatrelvir/Ritonavir | 35 | 35 |
| Lorazepam | Lorazepam | 33 | 13 |
| Verapamil Er | Verapamil Hcl | 33 | suppressed |
| Baclofen | Baclofen | 32 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 32 | 12 |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 30 | 11 |
| Folic Acid | Folic Acid | 30 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 30 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 30 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 29 | 12 |
| Levofloxacin | Levofloxacin | 29 | 23 |
| Mirtazapine | Mirtazapine | 29 | 11 |
| Solifenacin Succinate | Solifenacin Succinate | 29 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 28 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 27 | suppressed |
| Repaglinide | Repaglinide | 27 | suppressed |
| Sotalol | Sotalol Hcl | 27 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 27 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 26 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 21 |
| Ondansetron Odt | Ondansetron | 25 | 19 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 24 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 24 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 24 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 24 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 24 | 13 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 24 | 14 |
| Estradiol | Estradiol | 23 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 23 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Galantamine Er | Galantamine Hbr | 22 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 22 | suppressed |
| Advair Hfa | Fluticasone Propion/Salmeterol | 21 | suppressed |
| Memantine Hcl | Memantine Hcl | 21 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 21 | suppressed |
| Celecoxib | Celecoxib | 20 | suppressed |
| Mupirocin | Mupirocin | 20 | 17 |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 19 | 11 |
| Febuxostat | Febuxostat | 19 | suppressed |
| Lansoprazole | Lansoprazole | 19 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 19 | 18 |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 19 | suppressed |
| Chlorthalidone | Chlorthalidone | 18 | suppressed |
| Ketoconazole | Ketoconazole | 18 | 11 |
| Metronidazole | Metronidazole | 18 | 17 |
| Clonidine Hcl | Clonidine Hcl | 17 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Premarin | Estrogens, Conjugated | 17 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 16 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 16 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 16 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 16 | suppressed |
| Diphenoxylate-Atropine | Diphenoxylate Hcl/Atropine | 16 | suppressed |
| Dutasteride | Dutasteride | 16 | suppressed |
| Irbesartan-Hydrochlorothiazide | Irbesartan/Hydrochlorothiazide | 16 | suppressed |
| Methocarbamol | Methocarbamol | 16 | suppressed |
| Prochlorperazine Maleate | Prochlorperazine Maleate | 16 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 16 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 15 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 15 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 15 | suppressed |
| Telmisartan-Hydrochlorothiazid | Telmisartan/Hydrochlorothiazid | 15 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 15 | suppressed |
| Anastrozole | Anastrozole | 14 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Levalbuterol Tartrate Hfa | Levalbuterol Tartrate | 14 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | suppressed |
| Nystatin | Nystatin | 14 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 14 | suppressed |
| Torsemide | Torsemide | 14 | suppressed |
| Xarelto | Rivaroxaban | 14 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 13 | suppressed |
| Galantamine Hbr | Galantamine Hbr | 13 | suppressed |
| Gemfibrozil | Gemfibrozil | 13 | suppressed |
| Glipizide | Glipizide | 13 | suppressed |
| Lactulose | Lactulose | 13 | suppressed |
| Linzess | Linaclotide | 13 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 13 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 12 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 12 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 12 | suppressed |
| Jantoven | Warfarin Sodium | 12 | suppressed |
| Nortriptyline Hcl | Nortriptyline Hcl | 12 | suppressed |
| Rybelsus | Semaglutide | 12 | suppressed |
| Aripiprazole | Aripiprazole | 11 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 11 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 11 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 11 | suppressed |
| Ezetimibe-Simvastatin | Ezetimibe/Simvastatin | 11 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 11 | suppressed |
| Pregabalin | Pregabalin | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Xifaxan | Rifaximin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $19.77 · 1 records | AstraZeneca Pharmaceuticals LP | — | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error